In the SW480 and SW1116 cancer cells, Western blot analyses showed that treatment by 100 nM CBG induced a significant, progressive decrease in the levels of cyclin B and conspicuous accumulation of CDK1-pT15 (Additional file 3: Figure S3C), indicating activation of the G2/M cell cycle checkpoint. The gene discussed is CDK1; the disease is cancer.